Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Lecocq

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
DNA (Mary Ann Liebert, Inc.)|January 1, 1984
Linker tailing: unphosphorylated linker oligonucleotides for joining DNA terminiR Lathe, M P Kieny, S Skory, et al.
Vaccine|October 1, 1990
Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitisF Wild, P Giraudon, D Spehner, et al.
Journal of Molecular and Applied Genetics|January 1, 1984
M13 bacteriophage vectors for the expression of foreign proteins in Escherichia coli: the rabies glycoproteinR F Lathe, M P Kieny, D Schmitt, et al.
Nucleic Acids Research|November 25, 1982
Silica gel: an improved support for the solid-phase phosphotriester synthesis of oligonucleotidesV Kohli, A Balland, M Wintzerith, et al.
European Journal of Immunology|February 1, 1993
Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodiesD Grezel, M Capron, J M Grzych, et al.
Vaccine|June 1, 1990
Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour developmentG Meneguzzi, M P Kieny, J P Lecocq, et al.
Journal of Virology|March 1, 1991
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env proteinB Guy, M Geist, K Dott, et al.
Nature|January 10, 1985
Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosisM Courtney, S Jallat, L H Tessier, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinR Drillien, D Spehner, A Kirn, et al.
The Journal of Clinical Investigation|June 1, 1986
Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individualsJ F Mornex, A Chytil-Weir, Y Martinet, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
DNA (Mary Ann Liebert, Inc.)|January 1, 1984
Linker tailing: unphosphorylated linker oligonucleotides for joining DNA terminiR Lathe, M P Kieny, S Skory, et al.
Vaccine|October 1, 1990
Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitisF Wild, P Giraudon, D Spehner, et al.
Journal of Molecular and Applied Genetics|January 1, 1984
M13 bacteriophage vectors for the expression of foreign proteins in Escherichia coli: the rabies glycoproteinR F Lathe, M P Kieny, D Schmitt, et al.
Nucleic Acids Research|November 25, 1982
Silica gel: an improved support for the solid-phase phosphotriester synthesis of oligonucleotidesV Kohli, A Balland, M Wintzerith, et al.
European Journal of Immunology|February 1, 1993
Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodiesD Grezel, M Capron, J M Grzych, et al.
Vaccine|June 1, 1990
Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour developmentG Meneguzzi, M P Kieny, J P Lecocq, et al.
Journal of Virology|March 1, 1991
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env proteinB Guy, M Geist, K Dott, et al.
Nature|January 10, 1985
Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosisM Courtney, S Jallat, L H Tessier, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinR Drillien, D Spehner, A Kirn, et al.
The Journal of Clinical Investigation|June 1, 1986
Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individualsJ F Mornex, A Chytil-Weir, Y Martinet, et al.
Pageof 8